Beta-blockers, along with ACE inhibitors, are considered first-line drugs in the treatment of CHF, as they can improve the survival rates and hospitalization of patients, effectively increase the ejection fraction (EF), and reduce the mass and sphericity of the left ventricle (LV) [12]. Here, ACE is linked to congestive heart failure.